AXL activates YAP through the EGFR–LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma
Article in Oncogene (August 2023)
The most recent citing publications are shown below. View all 116 publications that cite this research output on Dimensions.
Article in Oncogene (August 2023)
Article in International Journal of Molecular Sciences (June 2023)
Article in Frontiers in Endocrinology (June 2023)